Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group

The Ocular Histoplasmosis Study-Krypton Laser is a multicenter controlled clinical trial designed to determine whether krypton red laser photocoagulation is of value in preventing visual acuity loss in eyes with ocular histoplasmosis that have either choroidal neovascularization 1 to 199 micron from the center of the foveal avascular zone (FAZ) or choroidal neovascularization 200 micron or further from the FAZ center with blood and pigment extending within 200 micron of the FAZ center. Patients were assigned to photocoagulation (n = 143) or to observation only (n = 145). Recruitment of patients with such lesions has been stopped because more untreated eyes than treated eyes had experienced severe visual acuity loss. At one year after randomization, 24.8% (31/125) of untreated eyes, in contrast with 6.6% (8/121) of treated eyes, had lost six or more lines of visual acuity; by three years after randomization, the corresponding values were 24.6% (15/61) and 4.6% (3/64). The superiority of treatment was evident at every point in time after six months. There were no subgroups in which there was convincing evidence that treatment was harmful. Follow-up of all patients continues to assess long-term results of treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation
Hogan et al.
Br. J. Ophthalmol. 2005;89:1109-1111.
ABSTRACT | FULL TEXT  

Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5
Submacular Surgery Trials Research Group
Arch Ophthalmol 2005;123:78-88.
ABSTRACT | FULL TEXT  

Patients' Perceptions of the Value of Current Vision: Assessment of Preference Values Among Patients With Subfoveal Choroidal Neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1856-1867.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

Differentiation Between Presumed Ocular Histoplasmosis Syndrome and Multifocal Choroiditis With Panuveitis Based on Morphology of Photographed Fundus Lesions and Fluorescein Angiography
Parnell et al.
Arch Ophthalmol 2001;119:208-212.
ABSTRACT | FULL TEXT  

Visual Outcome After Surgical Removal of Choroidal Neovascularization in Pediatric Patients
Uemura and Thomas
Arch Ophthalmol 2000;118:1373-1378.
ABSTRACT | FULL TEXT  

Immunosuppressive Treatment of Choroidal Neovascularization Associated With Endogenous Posterior Uveitis
Dees et al.
Arch Ophthalmol 1998;116:1456-1461.
ABSTRACT | FULL TEXT  

Clinicopathological correlation of an excised choroidal neovascular membrane in pseudotumour cerebri
Castellarin et al.
Br. J. Ophthalmol. 1997;81:994-1000.
ABSTRACT | FULL TEXT